c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors

Type II testicular germ cell tumors (TGCTs) represent the most frequent malignancy in Caucasian males (20–40 years). Even if diagnosed with disseminated disease, >80% of patients are cured; however, a small percentage of cases progress and result in death. It is commonly accepted that these cance...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Scheri, Katia Corano, Leonetti, Erica, Laino, Luigi, Gigantino, Vincenzo, Gesualdi, Luisa, Grammatico, Paola, Bizzari, Mariano, Franco, Renato, Oosterhuis, J. Wolter, Stoop, Hans, Looijenga, Leendert H.J., Ricci, Giulia, Catizone, Angela
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6112764/
https://ncbi.nlm.nih.gov/pubmed/30159127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25867
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller